2024 IBC, Security, and IACUC Conferences
IBC, Security, and IACUC Hybrid Conferences
NWABR will host its annual IBC, Security, and IACUC conferences in a hybrid format in 2024. The hybrid format allows attendees the option of attending the conferences In Person or Virtually.
The hybrid conferences will take place on consecutive days (February 27, 2024 for IBC, February 28, 2024 for Security, and February 29, 2024 for IACUC). There is also an option of an add on half day (March 1, 2024) which be a small group facility tour with a local research institution. This half day will be free for all conference registrants.
Attendees will be able to register separately for each day or register to attend multiple conferences.
The Planning Committees have decided that the overarching themes for the three conferences will be "At the Leading Edge of Research".
The programs and speakers for the three conferences are currently being finalized and will be updated here as the programs are confirmed.
IBC Conference - Confirmed Speakers and Topics - February 27, 2024
- Chris Doyle (WCG, Co-chair)
- James Riddle (Advarra, Co-chair)
- Melissa Tribelhorn (NWABR)
- Lesley Colby (University of Washington)
- Aaron Putzke (Whitworth University)
- Sarah Byers (Oregon Health and Science University)
- Harjinder Sardar (Oregon Health and Science University)
- Karen Sanguinet (Washington State University)
- Antony Schwartz (Duke School of Medicine - representing ABSA)
- Jon Oatley (Washington State University)
- Bob Ellis (Colorado State University)
- Zach Aldeman (Texas AMU)
- Kathryn Harris (NIH, TBC)
- Susan Parazzoli (Fred Hutchinson Cancer Center)
Security Conference - Confirmed Speakers and Topics - February 28, 2024
- Chris Oehmen (PNNL, Co-chair)
- Melissa Tribelhorn (NWABR)
- Whitney Bowman-Zatzkin (BIO-ISAC)
- Charles Fracchia (BIO-ISAC)
- Bill Reid (Google)
- Jana Spring (CISA)
- Noé Isaac Cavazos, J.D. (CISA)
- Paul “Bo” Stocklin (CISA)
- James Diggins (Twist Bioscience)
IACUC Conference - Confirmed Speakers and Topics - February 29, 2024
- Heather Sidener (Oregon Health and Science University, Co-chair)
- Shannon Ramsey (Allen Institute, Co-chair)
- Melissa Tribelhorn (NWABR)
- Erin Straley (AstraZeneca)
- Megan La Follette (The 3Rs Collaborative)
- Brianna Gaskill (Novartis)
- Brent Morse (OLAW)
- USDA (TBC)
- Helen Diggs or alternate (AAALAC)
- Sally Thompson-Iritani (ILAR)
- Chad Foster (NASA)
- Christina Cruzen (University of Washington)
- Leenoy Meshulam (University of Washington)
- Michelle Steinauer (Western University of Health Sciences)
- Cindy Pekow (Veterans Affairs Puget Sound)
- Joan Phillips (Oregon Health and Science University)
- Esther Pearl (National Centre for the Replacement, Refinement and Reduction of Animals in Research)
Optional Bridging the Gap Facility Tour - March 1, 2024 (In Person Attendees Only)
NWABR, in partnership with the University of Washington, Office of Animal Welfare, is offering a free add on session that will allow a small group of registered attendees to participate in a tour of a local research institution's animal care and use facilities. The Bridging the Gap Tour is only available for In Person attendees. This year a group of up to 20 attendees will have the opportunity to tour research facilities in a downtown Seattle campus, including state of the art facilities in a recently constructed vivarium. More details will be provided to prospective attendees on request.
In Person Conferences
The Conference is being hosted at the Seattle Children's Research Institute: Building Cure, 1920 Terry Ave., Seattle, WA 98101. Parking in this area is limited (and expensive) so attendees are encouraged to use public transport. The Building Cure facility is an 11-minute walk from the Westlake Light Rail Station.
For those attendees attending the Conferences Virtually, we will broadcast the programs using WebEx. This program allows the sharing of presenter slides and videos and limited audience interaction. With the permission of the presenters all presentations will be recorded and will be available by March 4, 2024.
Virtual attendance at each conference will be $150 and if attendees want to attend for two or three days then the combined fee will be $275.
In Person attendance will be $300 at each conference and if attendees want to attend for two or three days then the combined fee will be $550. In Person attendees will receive breakfast, lunch, and refreshments during the day and will be welcomed to join for a hosted happy hour to conclude each conference.
Staff members of NWABR Member organizations can register at a discounted rate by using the code NWABRMEMBER. A full list of NWABR Member organizations can be found on the member page of the NWABR website. The discounted rate for NWABR members is a 47% saving on the prices noted above.
There is an additional discount if NWABR Member organizations wish to register ten or more attendees. Please contact NWABR staff for this discount code.
Students with a focus on IBC, IACUC, or Biomedical Research Security can register for $10 for the full three-day virtual conference series.
NWABR will be applying for the following CE credits:
- CPIA Recertification Credits.
- ABSA CM points for RBP/CBSP Maintenance.
- The American Association of Veterinary State Boards RACE credit for Veterinarians and Veterinary Technicians.
Sponsorship support is key to the successful provision of these events. NWABR acknowledges the following sponsors of these conferences:
Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted IRB and IBC review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster.
WCG IBC Services is the unrivaled leader in IBC management and biosafety review. Since its inception in 2000, WCG IBC Services has reviewed more human gene transfer clinical trials and convened more IBC meetings than any other provider, while delivering expert biosafety oversight to more than 1,100 institutions in over 20 countries around the world. For more information, visit https://wcgirb.com/services/ibc-administration-review.
The FBI is the lead federal agency for responding to threats from chemical, biological, radiological, and nuclear (CBRN) threats. The FBI investigates and collects intelligence on CBRN and explosive-related threats and incidents to prevent attacks and respond to them when they occur.
Established in 2006, the Weapons of Mass Destruction Directorate (WMDD) is part of the FBI’s National Security Branch. The WMDD leads the FBI’s efforts to mitigate threats from CBRN or explosive weapons. FBI personnel work with academic and industry partners to protect advances in scientific research and biotechnology development and to prevent the misuse of biological knowledge, material, and technology. The FBI also supports U.S. health security in part by coordinating with Global Health Security Agenda partners, Federal, State, Local and Tribal health partners to prevent, detect, and respond to biological incidents.
The traditional distinction between national security and criminal matters is increasingly blurred as terrorists commit crimes to finance their activities and computer hackers create vulnerabilities that can be exploited. The FBI is uniquely positioned and is the lead agency for exposing, preventing, and investigating intelligence activities, including espionage, on U.S. soil and uses its investigative and intelligence capabilities--as well as strategic partnerships--to pursue spies. Additionally, the FBI’s is tasked with investigating cyber-attacks and intrusions. We collect and share intelligence and engage with victims while working to unmask those committing malicious cyber activities, wherever they are.
The partnerships referenced above are crucially important to the success of this vital mission of protecting the United States from these threats. We look forward to interacting with you during the week and thank you in advance for your participation.
As an independent, nonprofit biomedical research institution founded in 1929, JAX leverages its unique combination of research, education and resources to achieve its mission: to discover precise genomic solutions for disease and empower the global biomedical community in its shared quest to improve human health. For more information, visit www.jax.org.
PMI is the International supplier of the LabDiet® and TestDiet® products used in lab animal nutrition. All products are manufactured in our FSSC 22000 Certified plant in Richmond, IN. Diets are available in Standard, Certified, Autoclavable, Irradiated, Vac-Pak and Micro-Pak. Custom diets are also available upon request. For more information, visit www.labdiet.com or www.testdiet.com.
Additional Sponsors and Vendors are welcome for this conference. Potential sponsors are encouraged to contact NWABR Executive Director, Ms. Melissa Tribelhorn for more information (Melissa@nwabr.org)
NWABR has arranged for a block of rooms at the Hilton Garden Inn Seattle Downtown (HGISD). The address for the HGISD is: 1821 Boren Avenue, Seattle, WA 98101. The GHGISD is easily accessible to the Light Rail system (an 11-minute walk) if attendees are flying into Seattle. The HGISD is just one block from the conference venue. Bookings with the HGISD need to be confirmed by February 12, 2024, to secure the discounted rates that have been arranged.
Booking Link: Book Here
Hotel: Hillton Garden In Seattle Downtown
Group Name: Northwest Association for Biomedical Research
Arrival Date: February 26, 2024
Departure Date: March 1, 2024
If you wish more information about these important regional conferences, NWABR and/or NWABR membership then please contact, NWABR Executive Director, Ms. Melissa Tribelhorn (email: Melissa@nwabr.org, phone: (206) 957-3337). Please note NWABR reserves the right to deny registration for any reason.